J&J | JNJ - مصاريف البيع والإدارة





مصاريف البيع والإدارة تغيير تاريخ
AbbVie USD 3.84B 205M 2026-09
Abbott USD 4.27B 669M 2026-09
Amgen USD 1.68B 40M 2026-09
AstraZeneca USD 4.07B 1.73B 2026-09
Baxter International USD 730M 5M 2026-09
Bayer EUR 4.02B 53M 2026-09
Becton, Dickinson and Co. USD 1.26B 1000K 2026-09
Biogen USD 752M 42.3M 2026-09
Boston Scientific USD 1.68B 120M 2026-09
Bristol-Myers Squibb USD 1.7B 127M 2026-09
CONMED USD 136.42M 9.14M 2026-09
Cooper Companies USD 401.3M 274.9M 2026-06
Dexcom USD 358.7M 9M 2026-06
Edwards Lifesciences USD 560.9M 300K 2026-09
Eli Lilly USD 3.12B 305M 2026-09
Gilead Sciences USD 1.52B 70M 2026-06
GlaxoSmithKline GBP 2.16B 39M 2026-09
Globus Medical USD 288.47M 1.65M 2026-09
Insulet USD 350.7M 5.9M 2026-09
Integra LifeSciences USD 161.02M 5.2M 2026-09
Intuitive Surgical USD 1.08B 465.5M 2026-09
J&J USD 6.25B 168M 2026-09
Medtronic 3.2B 141M 2026-06
Merck USD 2.86B 25M 2026-09
Merit Medical Systems USD 129.23M 18.76M 2026-06
Novartis USD 3.08B 163M 2026-09
Pfizer USD 3.28B 132M 2026-09
Regeneron Pharmaceuticals USD 662.1M 14.4M 2026-06
Roche Holding CHF 6.37B 908M 2026-06
Sanofi EUR 2.31B 325M 2026-09
Stryker USD 2.12B 32M 2026-06
Tandem Diabetes Care USD 113.94M 2.3M 2026-09
Teva Pharmaceutical Industries USD 1.01B 27M 2026-09
Vertex Pharmaceuticals USD 556.3M 25.9M 2026-09
Zimmer Biomet Holdings USD 855M 56.6M 2026-09
Zoetis USD 582M 10M 2026-09